42 results
8-K
EX-99.1
RNLX
Renalytix Plc
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
and distributed and marketed, the rate of testing with KidneyIntelX in health care systems, expectations and timing of announcement of real-world testing
8-K
RNLX
Renalytix Plc
23 Apr 24
Entry into a Material Definitive Agreement
5:00pm
of health care continuation under the COBRA benefits until the earliest of (a) April, 2025, (b) the date Mr. McLain becomes eligible for substantially
8-K
EX-99.1
RNLX
Renalytix Plc
14 Mar 24
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
7:15am
treatment strategies for health care professionals and we look forward to continuing to release evidence to highlight the role that KidneyIntelX is playing
8-K
EX-10.1
RNLX
Renalytix Plc
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
company which is a member of the Group (including the Company) and "Group Companies" shall be construed accordingly;
"Health Care Laws" has the meaning … in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications.
13 COMPLIANCE WITH HEALTH CARE LAWS
8-K
EX-99.1
RNLX
Renalytix Plc
15 Feb 24
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
7:00am
in health care systems, expectations and timing of announcement of real-world testing evidence, the potential for KidneyIntelX to be approved for additional
8-K
EX-99.1
beurmza
14 Nov 23
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
12:00am
10-Q
i8p4z
14 Nov 23
Quarterly report
12:00am
8-K
EX-99.1
wbccejy z3
28 Sep 23
Renalytix Reports Full Year Fiscal 2023 Results
7:31am
10-K
8e931b1d
28 Sep 23
Annual report
6:18am
10-K
EX-10.7
26rn4tlui ughvjlbt
28 Sep 23
Annual report
6:18am
10-K
EX-10.8
8g8p l12afg578
28 Sep 23
Annual report
6:18am
10-K
EX-10.6
lwi3qd zu7eqyuso6bed
28 Sep 23
Annual report
6:18am
8-K
u94 br4wz5
22 Sep 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
6e2xf30
3 Jul 23
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
2:30pm
6-K
EX-99.1
xr8mz4bnk2riiso0
30 Jun 23
Current report (foreign)
7:00am
6-K
fmus zwgx83b
9 Jun 23
Current report (foreign)
7:01am
6-K
3tcivb6hm70csf9t79
22 May 23
Current report (foreign)
7:00am
6-K
x4y7xpp319c3g03
30 Mar 23
Current report (foreign)
7:01am
6-K
h6uafrf6xoowummoul
30 Nov 22
Current report (foreign)
7:31am
6-K
EX-99.1
i5ec70j
29 Nov 22
Current report (foreign)
7:01am